Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
<Composition xmlns="http://hl7.org/fhir">
<id value="375280"/>
<meta>
<versionId value="83"/>
<lastUpdated value="2025-08-12T18:22:53.937Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/outcome-measure-report"/>
</meta>
<language value="en"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><p class="res-header-id"><b>Generated Narrative: Composition 375280</b></p><a name="375280"> </a><a name="hc375280"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 83; Last updated: 2025-08-12 18:22:53+0000; Language: en</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-outcome-measure-report.html">OutcomeMeasureReport</a></p></div><p><b>Artifact Description</b>: </p><div><p>This is an example of an Outcome Measure Report describing the QUARTET USA Randomized Clinical Trial for the EBM on FHIR Implementation Guide.</p>
</div><p><b>url</b>: <a href="https://fevir.net/resources/Composition/375280">https://fevir.net/resources/Composition/375280</a></p><p><b>identifier</b>: FEvIR Object Identifier/375280</p><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 OutcomeMeasureReport}">Outcome Measure Report</span></p><p><b>date</b>: 2025-08-12 18:22:53+0000</p><p><b>author</b>: Joanne Dehnbostel</p><p><b>title</b>: Outcome Measure Report for QUARTET USA Trial</p><p><b>custodian</b>: <a href="Organization-118079.html">Computable Publishing LLC</a></p><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Part Of</p><p><b>target</b>: <a href="Composition-372776.html">Comparative Evidence Report for QUARTET USA Trial</a></p></blockquote><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Cite As</p><p><b>target</b>: </p><div><p>Outcome Measure Report for QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375280. Revised 2025-08-12. Available at: https://fevir.net/resources/Composition/375280. Computable resource at: https://fevir.net/FLI/DocumentForComposition375280.</p>
</div></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-description">
<valueMarkdown
value="This is an example of an Outcome Measure Report describing the QUARTET USA Randomized Clinical Trial for the EBM on FHIR Implementation Guide."/>
</extension>
<url value="https://fevir.net/resources/Composition/375280"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="375280"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<status value="final"/>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="OutcomeMeasureReport"/>
<display value="OutcomeMeasureReport"/>
</coding>
<text value="Outcome Measure Report"/>
</type>
<date value="2025-08-12T18:22:53.937Z"/>
<author>
<display value="Joanne Dehnbostel"/>
</author>
<title value="Outcome Measure Report for QUARTET USA Trial"/>
<custodian>🔗
<reference value="Organization/118079"/>
<type value="Organization"/>
<display value="Computable Publishing LLC"/>
</custodian>
<relatesTo>
<type value="part-of"/>
<targetReference>🔗
<reference value="Composition/372776"/>
<type value="Composition"/>
<display value="Comparative Evidence Report for QUARTET USA Trial"/>
</targetReference>
</relatesTo>
<relatesTo>
<type value="cite-as"/>
<targetMarkdown
value="Outcome Measure Report for QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375280. Revised 2025-08-12. Available at: https://fevir.net/resources/Composition/375280. Computable resource at: https://fevir.net/FLI/DocumentForComposition375280."/>
</relatesTo>
<section>
<title value="Group List"/>
<code>
<text value="GroupList"/>
</code>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<entry>🔗
<reference value="Group/375175"/>
<type value="Group"/>
<display value="QUARTET USA Trial Quadpill group"/>
</entry>
<entry>🔗
<reference value="Group/375182"/>
<type value="Group"/>
<display value="QUARTET USA Trial Control Group"/>
</entry>
<entry>🔗
<reference value="EvidenceVariable/375183"/>
<type value="EvidenceVariable"/>
<display value="GroupAssignment: Quadpill vs. Candesartan"/>
</entry>
</section>
<section>
<title value="Results for Systolic blood pressure at 12 weeks"/>
<code>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="results"/>
<display value="Results"/>
</coding>
</code>
<focus>🔗
<reference value="EvidenceVariable/375185"/>
<type value="EvidenceVariable"/>
<display value="Systolic blood pressure at 12 weeks"/>
</focus>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<entry>🔗
<reference value="Evidence/375628"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"/>
</entry>
<entry>🔗
<reference value="Evidence/375594"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"/>
</entry>
<entry>🔗
<reference value="Evidence/375907"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
</entry>
</section>
<section>
<title value="Results for Diastolic blood pressure at 12 weeks"/>
<code>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="results"/>
<display value="Results"/>
</coding>
</code>
<focus>🔗
<reference value="EvidenceVariable/375186"/>
<type value="EvidenceVariable"/>
<display value="Diastolic blood pressure at 12 weeks"/>
</focus>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<entry>🔗
<reference value="Evidence/375629"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"/>
</entry>
<entry>🔗
<reference value="Evidence/375932"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"/>
</entry>
<entry>🔗
<reference value="Evidence/375933"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
</entry>
</section>
<section>
<title value="Results for Medication Adherence at 12 weeks"/>
<code>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="results"/>
<display value="Results"/>
</coding>
</code>
<focus>🔗
<reference value="EvidenceVariable/375201"/>
<type value="EvidenceVariable"/>
<display value="Medication Adherence at 12 weeks"/>
</focus>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<entry>🔗
<reference value="Evidence/379723"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Quadpill group"/>
</entry>
<entry>🔗
<reference value="Evidence/379724"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Control Group"/>
</entry>
<entry>🔗
<reference value="Evidence/379725"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
</entry>
</section>
<section>
<title value="Results for Hypertension Control at 12 weeks"/>
<code>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="results"/>
<display value="Results"/>
</coding>
</code>
<focus>🔗
<reference value="EvidenceVariable/375202"/>
<type value="EvidenceVariable"/>
<display value="Hypertension Control at 12 weeks"/>
</focus>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<entry>🔗
<reference value="Evidence/379736"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group"/>
</entry>
<entry>🔗
<reference value="Evidence/379737"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Control Group"/>
</entry>
<entry>🔗
<reference value="Evidence/379738"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
</entry>
</section>
<section>
<title value="Results for Add-on Amlodipine at 6 weeks"/>
<code>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="results"/>
<display value="Results"/>
</coding>
</code>
<focus>🔗
<reference value="EvidenceVariable/375203"/>
<type value="EvidenceVariable"/>
<display value="Add-on Amlodipine at 6 weeks"/>
</focus>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<entry>🔗
<reference value="Evidence/379739"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Quadpill group"/>
</entry>
<entry>🔗
<reference value="Evidence/379740"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Control Group"/>
</entry>
<entry>🔗
<reference value="Evidence/379741"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
</entry>
</section>
<section>
<title
value="Results for Adverse event free and hypertension control at 12 weeks"/>
<code>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="results"/>
<display value="Results"/>
</coding>
</code>
<focus>🔗
<reference value="EvidenceVariable/375278"/>
<type value="EvidenceVariable"/>
<display
value="Adverse event free and hypertension control at 12 weeks"/>
</focus>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<entry>🔗
<reference value="Evidence/379742"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group"/>
</entry>
<entry>🔗
<reference value="Evidence/379743"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Control Group"/>
</entry>
<entry>🔗
<reference value="Evidence/379744"/>
<type value="Evidence"/>
<display
value="Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
</entry>
</section>
</Composition>
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-09-04
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change